Shanghai Shyndec Pharmaceutical Co., Ltd.SSE: 600420

Report for Q1 2025

Apr 29, 2025 · Issued by Shanghai Shyndec Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 29, 2025

On 6ix: 6ix.com/news/report-for-q1-2025-52

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix

Later from Shanghai Shyndec Pharmaceutical

Announcement on Attending Collective Annual Report Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025May 9, 2025
Announcement on the Holding Subsidiary Obtaining the Approval Notice for Drug Supplementary ApplicationMay 29, 2025
Announcement on Resolution of the 22nd Meeting of the 8th Board of DirectorsJun 6, 2025
Announcement on Progress in Accepting Drug Marketing Authorization by Holding SubsidiaryJun 11, 2025
Announcement on the Voluntary Information Disclosure of the Holding Subsidiary's Drug Passing the Consistency Evaluation for Generic DrugsJun 21, 2025

All Shanghai Shyndec Pharmaceutical news releases

Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.

Follow Shanghai Shyndec Pharmaceutical